Phenacetin
Phenacetin is a painkiller and fever reducer that was widely used in the late 19th and early 20th centuries. It was one of the first non-opioid analgesics to be discovered and was a key ingredient in many popular over-the-counter drug formulations. However, due to its association with serious health problems, including cancer and kidney disease, it has been largely phased out and is no longer commercially available in many countries.
History[edit]
Phenacetin was first synthesized in 1878 by the German chemist Harmon Northrop Morse. It was initially marketed as a treatment for fever and pain, and was included in a number of popular drug mixtures, including the headache remedy "Bayer's 'Phenacetin-Koffein'". However, by the mid-20th century, evidence began to emerge linking phenacetin to serious health problems, leading to its gradual withdrawal from the market.
Pharmacology[edit]
Phenacetin is a prodrug that is metabolized in the body to paracetamol, which is the active compound that exerts the analgesic and antipyretic effects. The metabolism of phenacetin occurs primarily in the liver, involving two main enzymatic pathways: N-deethylation to paracetamol and O-deethylation to phenetidine.
Health effects[edit]
Long-term use of phenacetin is associated with serious health problems. It has been linked to methemoglobinemia, a blood disorder that reduces the ability of red blood cells to release oxygen to tissues, and nephropathy, a form of kidney disease. Phenacetin is also a known carcinogen, and its use has been linked to an increased risk of developing bladder cancer and renal pelvis cancer.
Legal status[edit]
Due to its health risks, phenacetin has been banned in many countries. In the United States, the Food and Drug Administration (FDA) banned the sale of phenacetin in 1983, citing its carcinogenicity and the risk of kidney damage. In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) withdrew phenacetin from the market in 1968.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
